Literature DB >> 17873118

Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations.

A Trizzino1, U zur Stadt, I Ueda, K Risma, G Janka, E Ishii, K Beutel, J Sumegi, S Cannella, D Pende, A Mian, J-I Henter, G Griffiths, A Santoro, A Filipovich, M Aricò.   

Abstract

BACKGROUND: PRF1 gene mutations are associated with familial haemophagocytic lymphohistiocytosis type 2 (FHL2). Genotype-phenotype analysis, previously hampered by limited numbers of patients, was for the first time performed by data pooling from five large centres worldwide. PATIENTS AND METHODS: Members of the Histiocyte Society were asked to report cases of FHL2 on specific forms. Data were pooled in a common database and analysed.
RESULTS: The 124 patients had 63 different mutations (including 15 novel mutations): 11 nonsense, 10 frameshift, 38 missense and 4 in-frame deletions. Some mutations were found more commonly: 1122 G-->A (W374X), associated with Turkish origin, in 32 patients; 50delT (L17fsX22) associated with African/African American origin, in 21 patients; and 1090-91delCT (L364fsX), in 7 Japanese patients. Flow cytometry showed that perforin expression was absent in 40, reduced in 6 and normal in 4 patients. Patients presented at a median age of 3 months (quartiles: 2, 3 and 13 months), always with fever, splenomegaly and thrombocytopenia. NK activity was absent in 36 (51%), <or=2% in 18 (26%), 3-<or=5% in 10 (14%), >5% in 4 (6%), "reduced" in 2 (3%) (not reported, n = 54). Nonsense mutations were significantly associated with younger age at onset (p<0.001) and absent natural killer activity (p = 0.008).
CONCLUSION: PRF1 mutations are spread over the functional domains. Specific mutations are strongly associated with Turkish, African American and Japanese ethnic groups. Later onset and residual cytotoxic function are observed in patients with at least one missense mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873118     DOI: 10.1136/jmg.2007.052670

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  48 in total

1.  Molecular basis of familial hemophagocytic lymphohistiocytosis.

Authors:  Valentina Cetica; Daniela Pende; Gillian M Griffiths; Maurizio Aricò
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function.

Authors:  Ramon Urrea Moreno; Juana Gil; Carmen Rodriguez-Sainz; Elena Cela; Victor LaFay; Brian Oloizia; Andrew B Herr; Janos Sumegi; Michael B Jordan; Kimberly A Risma
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

3.  Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.

Authors:  Kejian Zhang; Michael B Jordan; Rebecca A Marsh; Judith A Johnson; Diane Kissell; Jarek Meller; Joyce Villanueva; Kimberly A Risma; Qian Wei; Peter S Klein; Alexandra H Filipovich
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

Review 4.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

5.  A novel pathogenic variant in PRF1 associated with hemophagocytic lymphohistiocytosis.

Authors:  Camilo Andrés Pérez Romero; Isaura Pilar Sánchez; Sebastian Gutierrez-Hincapié; Jesús A Álvarez-Álvarez; Jaime Andres Pereañez; Rodrigo Ochoa; Carlos Enrique Muskus-López; Ruth G Eraso; Carolina Echeverry; Catalina Arango; José Luis Franco Restrepo; Claudia Milena Trujillo-Vargas
Journal:  J Clin Immunol       Date:  2015-05-15       Impact factor: 8.317

6.  Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocytic lymphohistiocytosis type 2 (FHL2) patients.

Authors:  Omer An; Attila Gursoy; Aytemiz Gurgey; Ozlem Keskin
Journal:  Protein Sci       Date:  2013-06       Impact factor: 6.725

7.  ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.

Authors:  Julia E Rood; Sheila Rao; Michele Paessler; Portia A Kreiger; Niansheng Chu; Erietta Stelekati; E John Wherry; Edward M Behrens
Journal:  Blood       Date:  2015-10-30       Impact factor: 22.113

8.  Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.

Authors:  Annahita K Sarcon; Marie J Desierto; Wenjun Zhou; Valeria Visconte; Federica Gibellini; Jichun Chen; Neal S Young
Journal:  Exp Hematol       Date:  2009-02-12       Impact factor: 3.084

9.  Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation.

Authors:  Cristina Dias; Allison McDonald; Murat Sincan; Rosemarie Rupps; Thomas Markello; Ramona Salvarinova; Rui F Santos; Kamal Menghrajani; Chidi Ahaghotu; Darren P Sutherland; Edgardo S Fortuno; Tobias R Kollmann; Michelle Demos; Jan M Friedman; David P Speert; William A Gahl; Cornelius F Boerkoel
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

10.  Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

Authors:  David T Teachey; Susan R Rheingold; Shannon L Maude; Gerhard Zugmaier; David M Barrett; Alix E Seif; Kim E Nichols; Erica K Suppa; Michael Kalos; Robert A Berg; Julie C Fitzgerald; Richard Aplenc; Lia Gore; Stephan A Grupp
Journal:  Blood       Date:  2013-05-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.